Pruritus Drug Market to 2027, Future Outlook, COVID-19 Impact Analysis, Forecast 2021-2027

The global pruritus drug market is expected to grow at a significant CAGR during the forecast period (2021-2027). The rising prevalence of pruritus cases globally increased expenditure for the development of healthcare infrastructure, and rising government policies and initiatives to offer a fund to many research institutes and pharmaceutical companies to introduce novel drugs and therapies are the major factors attributable to the growth of the global pruritus drug market.

A full report of Pruritus Drug Market is available at: https://www.omrglobal.com/industry-reports/pruritus-drug-market

Pruritus is a common skin condition that causes an uncomfortable sensation that makes you want to scratch or itch. In other terms, pruritus is a dermatological condition characterized by strong and persistent itching. Itching can be minor or severe, depending on the severity. Increased special designation from regulatory agencies is a crucial factor driving the pruritus medication industry forward. The global pruritus drugs market is also growing due to rising healthcare infrastructure spending and the rising prevalence of atopic dermatitis, allergic contact dermatitis, and urticaria. Furthermore, new medications such as Pimecrolimus cream and Tacrolimus ointment are projected to propel this market even further.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/pruritus-drug-market

Antihistamines are predicted to increase at a high rate during the forecast period, owing to their growing use as a first-line treatment and the presence of medicines in the pipeline with expected commercialization. However, the growth of the global pruritus drugs market will be hampered by unfavourable reimbursement scenarios in developing and undeveloped economies, as well as high treatment prices. The growth rate of the pruritus medicine industry will be hampered further by a lack of knowledge in growing and developing economies. The global market for pruritus drugs will be further slowed by the expiration of patents on branded drugs and the release of generic versions.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally
• Competitive Landscape: Pfizer Inc., AstraZeneca, Merck & Co., Inc., Sanofi US, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Pruritus Drug Market by Segment

By Drug Class

• Corticosteroids
• Antihistamines
• Counterirritants
• Other

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Pruritus Drug Market– Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Pfizer Inc.
• AstraZeneca
• Merck & Co., Inc.
• Sanofi US

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.